Titlebook: Levodopa-Induced Dyskinesia in Parkinson‘s Disease; Susan H. Fox,Jonathan M. Brotchie Book 2014 Springer-Verlag London 2014 Parkinson‘s di

显示全部楼层 · 发表于 2025-3-23 18:45:09

Pharmacological Treatment Options for Levodopa-Induced Dyskinesia,lude the antiglutamatergic drug amantadine and the antipsychotic clozapine (which carries a risk of leukopenia and requires regular blood checks)..In patients with motor complications refractory to all adjustments of oral and transdermal treatments and where deep brain stimulation is either contrain

显示全部楼层 · 发表于 2025-3-23 23:48:12

显示全部楼层 · 发表于 2025-3-24 02:23:18

Pharmacological Properties of Levodopa, which is thought to be a key determinant underlying the dyskinetic state. Therapeutic approaches that would produce continuous drug delivery (CDD) and ensuing continuous dopaminergic stimulation (CDS) have been actively sought. After a brief historical review, this chapter summarizes the biochemica

显示全部楼层 · 发表于 2025-3-24 07:27:59

显示全部楼层 · 发表于 2025-3-24 11:03:39

显示全部楼层 · 发表于 2025-3-24 16:24:08

Involvement of the Cholinergic System in Levodopa-Induced Dyskinesia, acting at nAChRs, with the α4β2, α6β2, and α7 receptor subtypes all contributing to the occurrence of LID. An involvement of multiple subtypes in LID is also supported by studies with drugs targeting select nAChR populations. Notably, nicotine and nAChR drugs did not worsen parkinsonism in any anim

显示全部楼层 · 发表于 2025-3-24 19:32:29

New Clinical Trials for Levodopa-Induced Dyskinesia,odopa-sparing agents on LID is also being investigated, both in early and advanced PD. Moreover, non-dopaminergic agents are being studied as add-on therapies in established LID. Such agents are also being studied in early PD, either as monotherapy to improve parkinsonian symptoms without causing dy

显示全部楼层 · 发表于 2025-3-25 02:43:52

ced Dyskinesia in Parkinson’s Disease. is aimed at an international audience of movement disorder neurologists; neuroscientists; trainees and graduate and post-graduate students..978-1-4471-7238-3978-1-4471-6503-3

显示全部楼层 · 发表于 2025-3-25 06:23:42

Elisabetta Tronci,Camino Fidalgo,Manolo Cartan anschließend wird der Versuch unternommen, Interessen in ihrem multidimensionalen und prozesshaften Charakter als „Interessierung“ neu zu fassen und in ihren Implikationen für Th978-3-658-33726-1978-3-658-33727-8

显示全部楼层 · 发表于 2025-3-25 11:08:36

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-23 06:11
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

Titlebook: Levodopa-Induced Dyskinesia in Parkinson‘s Disease; Susan H. Fox,Jonathan M. Brotchie Book 2014 Springer-Verlag London 2014 Parkinson‘s di

浏览过的版块